Clinical Trial Update: Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy

View source ↗

Summary

Clinical trial NCT01539681, conducted in Italy, evaluating sorafenib for hepatocellular carcinoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Hepatocellular Carcinoma | Status: COMPLETED